Natural antisense transcripts as drug targets

Natural antisense transcripts as drug targets

The recent discovery of vast non-coding RNA-based regulatory networks that can be easily modulated by nucleic acid-based drugs has opened numerous new therapeutic possibilities. Long non-coding RNA, and natural antisense transcripts (NATs) in particular, play a significant role in networks that invo...

Full description

Bibliographic Details
Main Authors:	Olga Khorkova, Jack Stahl, Aswathy Joji, Claude-Henry Volmar, Zane Zeier, Claes Wahlestedt
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Molecular Biosciences
Subjects:	natural antisense transcript (NAT) long nocoding RNA anisense oligonucleotides posttranscriptional regulation nucleic acid based therapeutics
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2022.978375/full

Similar Items

Development of a rapid and inexpensive method to reveal natural antisense transcripts
by: Collani Silvio, et al.
Published: (2012-09-01)

Asymmetric localization of natural antisense RNA of neuropeptide sensorin in Aplysia sensory neurons during aging and activity
by: Beena eKadakkuzha, et al.
Published: (2014-04-01)

Nucleic Acid–Based Therapeutics in Orphan Neurological Disorders: Recent Developments
by: Olga Khorkova, et al.
Published: (2021-04-01)

History of Research on Antisense Oligonucleotide Analogs
by: Jack S. Cohen
Published: (2021-03-01)

Natural antisense transcripts in the biological hallmarks of cancer: powerful regulators hidden in the dark
by: Shanshan Zhao, et al.
Published: (2020-09-01)

Nucleic acid-based therapeutics for the treatment of central nervous system disorders
by: Robyn McCartan, et al.
Published: (2023-08-01)

Therapeutic and diagnostic applications of antisense peptide nucleic acids
by: Victoria MacLelland, et al.
Published: (2024-03-01)

THERAPEUTIC ANTISENSE OLIGONUCLEOTIDES AGAINST CANCER: HURDLING TO THE CLINIC
by: Pedro Miguel Duarte Moreno, et al.
Published: (2014-10-01)

Antisense and Functional Nucleic Acids in Rational Drug Development
by: Robert Penchovsky, et al.
Published: (2024-02-01)

Antisense therapeutics /
by: Phillips, M. Ian
Published: (2005)

Targeting murine alveolar macrophages by the intratracheal administration of locked nucleic acid containing antisense oligonucleotides
by: Yasunori Uemura, et al.
Published: (2019-01-01)

Base-modified aptamers obtained by cell-internalization SELEX facilitate cellular uptake of an antisense oligonucleotide
by: Keisuke Tanaka, et al.
Published: (2021-03-01)

Quantitative fluorescence imaging of antisense oligonucleotide mediated knockdown
by: Chan, Nicholas Zhen Woon
Published: (2024)

Upregulation of Haploinsufficient Gene Expression in the Brain by Targeting a Long Non-coding RNA Improves Seizure Phenotype in a Model of Dravet Syndrome
by: J. Hsiao, et al.
Published: (2016-07-01)

Peptide nucleic acids, morpholinos and related antisense biomolecules /
by: 204120 Janson, Christopher G., et al.
Published: (2006)

Antisense drug technology : principles, strategies, and applications /
by: Crooke, Stanley T.
Published: (2008)

The Evolution of Antisense Oligonucleotide Chemistry—A Personal Journey
by: Sudhir Agrawal
Published: (2021-05-01)

Multi-targeted Antisense Oligonucleotide Delivery by a Framework Nucleic Acid for Inhibiting Biofilm Formation and Virulence
by: Yuxin Zhang, et al.
Published: (2020-03-01)

Antisense Therapy for Infectious Diseases
by: Lwanda Abonga Buthelezi, et al.
Published: (2023-08-01)

Antisense Oligonucleotide-Mediated Terminal Intron Retention of the SMN2 Transcript
by: Loren L. Flynn, et al.
Published: (2018-06-01)

A perspective on oligonucleotide therapy: Approaches to patient customization
by: Shikha Thakur, et al.
Published: (2022-10-01)

The Use of Antisense Oligonucleotides in Evaluating Survivin as a Therapeutic Target for Radiation Sensitization in Lung Cancer
by: Shinohara Eric T., et al.
Published: (2004-01-01)

Consequences of Making the Inactive Active Through Changes in Antisense Oligonucleotide Chemistries
by: Khine Zaw, et al.
Published: (2019-12-01)

LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY
by: O. I. Afanasieva, et al.
Published: (2015-09-01)

Antisense Oligonucleotide-Based Therapy of Viral Infections
by: Woan-Yuh Tarn, et al.
Published: (2021-11-01)

The Identification of <i>MATE</i> Antisense Transcripts in Soybean Using Strand-Specific RNA-Seq Datasets
by: Yee-Shan Ku, et al.
Published: (2022-01-01)

ANTISENSE OLIGONUCLEOTIDES AND THERAPEUTICAL MONOCLONAL ANTIBODIES AS A BASEMENT FOR NOVEL BIOLOGICAL LIPIDLOWERING DRUGS
by: O. I. Afanasieva, et al.
Published: (2018-09-01)

Cerebral Organoids and Antisense Oligonucleotide Therapeutics: Challenges and Opportunities
by: Jenny Lange, et al.
Published: (2022-06-01)

Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides
by: Anthony J Hinrich, et al.
Published: (2016-04-01)

In-silico study of antisense oligonucleotide antibiotics
by: Erica S. Chen, et al.
Published: (2023-11-01)

Antisense Transcription in Plants: A Systematic Review and an Update on cis-NATs of Sugarcane
by: Luciane Santini, et al.
Published: (2022-10-01)

Antisense oligonucleotide based therapeutics and its applications against bacterial infections
by: Nupur Angrish, et al.
Published: (2023-12-01)

Transport Oligonucleotides—A Novel System for Intracellular Delivery of Antisense Therapeutics
by: Oleg V. Markov, et al.
Published: (2020-08-01)

Antisense Transcripts and Antisense Protein: A New Perspective on Human Immunodeficiency Virus Type 1
by: Juliette Savoret, et al.
Published: (2021-01-01)

Antisense oligonucleotides for the arterial hypertension mechanisms study and therapy
by: L. O. Klimov, et al.
Published: (2018-04-01)

Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases
by: Valentina Giudice, et al.
Published: (2020-05-01)

Down-regulation of Survivin by Antisense Oligonucleotides Increases Apoptosis, Inhibits Cytokinesis and Anchorage-Independent Growth
by: Jun Chen, et al.
Published: (2000-05-01)

A novel knockout mouse model of the noncoding antisense Brain-Derived Neurotrophic Factor (Bdnf) gene displays increased endogenous Bdnf protein and improved memory function following exercise
by: Farzaneh Modarresi, et al.
Published: (2021-07-01)

Nonviral delivery systems for antisense oligonucleotide therapeutics
by: Si Huang, et al.
Published: (2022-09-01)

The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery
by: Maria Gagliardi, et al.
Published: (2021-04-01)